We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAT
8701
DELISTED
TransAtlantic Petroleum LTD.
TAT
$14K ﹤0.01%
+13,521
New +$16.1K
CLDX icon
8702
CALL
Celldex Therapeutics
CLDX
$3.28B
$13K ﹤0.01%
+4,420
New +$21.7K
IMUX icon
8703
Immunic
IMUX
$221M
$13K ﹤0.01%
177
-565
-76% -$66.1K
INUV icon
8704
Inuvo
INUV
$13.6M
$13K ﹤0.01%
1,248
-5,141
-80% -$46.2K
NTZ
8705
Natuzzi
NTZ
$14.6M
$13K ﹤0.01%
3,271
-587
-15% -$3.15K
PLX icon
8706
CALL
Protalix BioTherapeutics
PLX
$185M
$13K ﹤0.01%
4,330
+2,510
+138% +$11.9K
PRTS icon
8707
CarParts.com
PRTS
$50.3M
$13K ﹤0.01%
+1,388
New +$17.4K
PXS icon
8708
Pyxis Tankers
PXS
$52.2M
$13K ﹤0.01%
3,193
-3,470
-52% -$19.6K
VANI icon
8709
Vivani Medical
VANI
$116M
$13K ﹤0.01%
601
+120
+25% +$3.82K
VIRX
8710
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$13K ﹤0.01%
917
+308
+51% +$12.6K
BIOL
8711
DELISTED
Biolase, Inc.
BIOL
$13K ﹤0.01%
+5
New +$16.1K
TRVN
8712
PUT
DELISTED
Trevena, Inc.
TRVN
$13K ﹤0.01%
49
-11
-18% -$6.21K
KSPN
8713
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$13K ﹤0.01%
1,045
+472
+82% +$8.84K
OIG
8714
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$13K ﹤0.01%
+263
New +$18.3K
AMPE
8715
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$13K ﹤0.01%
108
-1
-0.9% -$153
RESN
8716
DELISTED
Resonant Inc.
RESN
$13K ﹤0.01%
+10,358
New +$25.3K
UUUU.WS
8717
DELISTED
Energy Fuels Inc.
UUUU.WS
$13K ﹤0.01%
10,484
-10,948
-51% -$15K
AXAS
8718
PUT
DELISTED
Abraxas Petroleum Corp
AXAS
$13K ﹤0.01%
+595
New +$20.7K
ANFI
8719
CALL
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$13K ﹤0.01%
30,300
+14,900
+97% +$11.4K
SDT
8720
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$13K ﹤0.01%
16,358
-7,294
-31% -$7.83K
EPE
8721
PUT
DELISTED
EP Energy Corporation
EPE
$13K ﹤0.01%
18,900
-12,100
-39% -$18.1K
NAVB
8722
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$13K ﹤0.01%
6,475
-220
-3% -$907
CPAH
8723
DELISTED
Counterpath Corp
CPAH
$13K ﹤0.01%
+11,045
New +$21.2K
GLOWE
8724
DELISTED
GLOWPOINT INC
GLOWE
$13K ﹤0.01%
104,000
-61,423
-37% -$7.68K
YDKG
8725
Yueda Digital Holding
YDKG
$5.81M
$12K ﹤0.01%
+24
New +$15.8K

Similar funds

Ken Griffin's Q4 2018 Portfolio in Review

As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.

  • Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Ken Griffin opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.